The prevalence of severely elevated low-density lipoprotein cholesterol (LDL-C) has declined in recent decades, but 1 in 17 US adults in a recent analysis had levels of LDL-C that would warrant ...

Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up to 62% with a single infusion. Not only was the experimental treatment successful, but ...

A single infusion of a CRISPR-based gene-editing therapy was associated with reductions in LDL cholesterol and triglycerides in patients with hard-to-treat lipid disorders, according to results from a ...

In 2015, a new class of cholesterol-lowering injectable drugs called PCSK9-inhibitors was approved by the Food and Drug ...

Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA —LDL cholesterol can be reduced to even more beneficial levels than ever before by use of a number ...

MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) announced today new data presented at the European Society of Cardiology Congress 2022 from its multinational prospective, ...

Results Validate In Vivo Liver DNA Base Editing as a Once-and-Done Approach to Treat Coronary Heart Disease by Lowering of LDL Cholesterol and PCSK9 Protein Levels CAMBRIDGE, Mass.--(BUSINESS ...

A 2010 meta-analysis of 26 RCTs (N = 169,138) examined the effectiveness of LDL-C lowering with statins. Patients were primarily from high-income regions, male, 50 to 70 years of age, and with or ...